[PDF] Top 20 FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE
Has 10000 "FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE" found on our website. Below are the top 20 most common "FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE".
FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE
... drug release studies showed the formulations from F4 and F7 could not sustain the release of the drug for ...drug release upto 24hrs. A slow and spread over the release of the drug for 24 hrs ... See full document
7
FORMULATION AND EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF LAMIVUDINE EMPLOYING HPMC K4M AND SODIUM ALGINATE
... a controlled release floating tablets of lamivudine employing HPMC K4M and sodium ...The floating tablets of lamivudine were prepared employing HPMC K4M and sodium ... See full document
5
Formulation and In-vitro Evaluation of Matrix Controlled Lamivudine Tablets
... Long term, intermediate and accelerated stability testing were carried out based on the ICH guidelines considering 25±2°C/60±5% RH, 30±2°C/65±5% RH and 40±2°C/75±5% RH respectively. One hundred tablets of batch F2 ... See full document
7
Formulation and In Vitro Evaluation of Lamivudine and Zidovudine Controlled Release Bilayer Matrix Tablets.
... al., Controlled-release (CR) medications offer many clinical and convenience advantages for patients as compared to immediate-release (IR) ... See full document
155
Formulation and evaluation of bilayered floating tablets of cefuroxime axetil
... matrix tablets of cephalosporin antibacterial drug cefuroxime axetil was formulated consist of IRL (50% dose) for quick onset of action and FRL (50% dose) for gastro retentive controlled drug release ... See full document
10
FORMULATION AND EVALUATION OF CONTROLLED RELEASE FLOATING TABLETS OF CEFIXIME USING HYDROPHILIC POLYMERS
... USP- type II dissolution apparatus (paddle type) was used for the dissolution study of prepared controlled release floating tablets. The temperature of dissolution flask was maintained at 37± ... See full document
5
FORMULATION AND IN VITRO EVALUATION OF FLOATING TABLETS OF TELMISARTAN
... each formulation were analyzed ...the tablets was found between 95-99% ...in vitro release studies were based on the mean content of the drug present in the respective ... See full document
15
Formulation and in vitro evaluation of bosentan osmatic controlled release tablets
... of controlled drug therapy All controlled release products share the common goal of improving drug therapy over that achieved with their non-controlled counter ...the controlled ... See full document
9
Formulation and In Vitro Evaluation of Controlled Release Matrix Tablets of Isradipine.
... extended release of drug were originally developed to reduce or eliminate unwanted effects such as gastrointestinal disturbances, nausea, and vomiting; the short half life of the drug also indicates the need for ... See full document
108
Formulation and Evaluation of Floating Controlled Release Tablets of Carvedilol by using Natural Polymers.
... developed formulation showed promise to be bioequivalent to the marketed product ...developed formulation was found to be ...Theophylline controlled release matrix tablets with Guar Gum ... See full document
128
FORMULATION AND EVALUATION OF RANITIDINE FLOATING CONTROLLED RELEASE TABLETS BY USING OKRA GUM
... hydrochloride release profiles of the floating tablets are shown in the (Table:6, 7) and ...hydrochloride release from floating tablets was shown and spread over 12h depended on ... See full document
8
FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF VALSARTAN
... retentive floating drug delivery system (GFDDS) of Valsartan to achieve prolonged release in the treatment of hypertension and myocardial ...sustained release floating formulations were ... See full document
15
Formulation and In-Vitro Evaluation of Gabapentin Oral Controlled Release Matrix Tablets
... Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. It has been proved to be ... See full document
112
Formulation and evaluation of gastroretentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs)
... the tablets increases with an increase in the polymer content as can be seen from the data given in tables-9 & ...In vitro floating studies were performed by placing tablets in USP XXIII ... See full document
44
FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF LORATADINE
... Intragastric floating gastrointestinal drug delivery system, Inflatable gastrointestinal drug delivery system, Intragastric osmotically controlled drug delivery system, Intra rumen controlled ... See full document
11
“Formulation and Evaluation of Theophylline Controlled Release Matrix Tablets by Using Natural Gums” by Pinnamraju Durga Nithya, Sajja Brahmani, Alapati Sriram, Nutalapati Prasanna Jaya Krishna, Poluri Koteswari, Puttagunta Srinivasa Babu, India.
... 10 tablets were selected and average weight was determined. Then the tablets were triturated to get a fine ...In vitro disintegration time ... See full document
5
Formulation and Devolopment of Floating Matrix Tablets of Lamivudine.
... oral controlled drug delivery systems should be primarily used to achieving more predictable and increased bioavailability of ...gastric floating drug delivery systems (GFDDS) offer numerous advantages over ... See full document
77
Formulation and Evaluation of Gastro Retentive Floating Tablets of Nimodipine
... hence floating drug delivery system (FDDS) is ...encapsulated floating tablets were formulated and characterized for enhancing residence time of drug in ...making floating gastro retentive ... See full document
9
Formulation Development and In-vitro Evaluation of Sustained Release Tablets of Carvedilol Solid Dispersion
... immediate release and repeated dosing of the drug which might lead to the risk of dose fluctuation, this arises the need of a formulation with control release that maintain a near-constant or uniform ... See full document
10
FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF LAMIVUDINE BY 22 FACTORIAL DESIGN
... of lamivudine is found to have many drawbacks, such as adverse side effects resulting from accumulation of drug in multidose therapy, poor patient compliance, and high ...cost. Controlled release ... See full document
9
Related subjects